Avian influenza: Ferret H7N9 flu model questioned

Journal name:
Nature
Volume:
501,
Page:
33
Date published:
DOI:
doi:10.1038/501033e
Published online

We question the relevance to human pandemics of studies designed to investigate transmissibility of the avian influenza A(H7N9) virus between ferrets (M. Richard et al. Nature http://doi.org/njc; 2013; see also R. A. M. Fouchier et al. Nature 500, 150151; 2013).

Earlier studies have demonstrated ferret transmission of wild-type A(H7N9) virus (H. Zhu et al. Science 341, 183186; 2013; and Q. Zhang et al. Science 341, 410414; 2013). However, the results are in striking contrast with the evidence that human-to-human transmission is extremely infrequent.

The discrepancy between ferret and human transmission in some strains undermines the purported value of 'gain-of-function' (GOF) experiments, which track genetically modified variants of A(H7N9). Yet these studies and a proposal to do GOF experiments (R. A. M. Fouchier et al. Nature 500, 150151; 2013) have been published without seriously questioning the relevance of the ferret model.

A naturally occurring virus could differ subtly from any produced experimentally. In that case, human transmissibility, antigenicity and drug resistance would need to be assessed by studies of the actual strain of virus, and data from GOF experiments could in fact be misleading.

The irony of GOF studies is that these results are likely to be useful for public health only if the pandemic arises from a lab accident, as many fear could happen if this work proliferates.

Author information

Affiliations

  1. Harvard School of Public Health, Boston, Massachusetts, USA.

    • Marc Lipsitch
  2. On behalf of 4 co-authors (see Supplementary Information for full author list). Two authors declare competing financial interests.

    • Marc Lipsitch

Competing financial interests

M.L. has received consulting income and honoraria from AIR Worldwide, Novartis, Pfizer and Outcome Sciences, the latter on a project funded by Roche. D.F. has received grant support from Novartis.

Corresponding author

Correspondence to:

Author details

Supplementary information

Additional data